Blood retinal barrier

Retinal Vascular Disease

Volumn , Issue , 2007, Pages 139-166

  Phillips, Brett E ^a   Antonetti, David A ^a   Berkowitz, Bruce A ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961002669     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-29542-6_8     Document Type: Chapter

References (269)

1. Agre P, Preston GM, Smith BL, Jung JS, Raina S, Moon C, Guggino WB, Nielsen S (1993) Aquaporin CHIP: the archetypal molecular water channel. Am J Physiol 265:F463-76
2. Aiello LP (1997) Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 8:19-31
3. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-7
4. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW (1997) Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthal-mol Vis Sci 38:36-47
5. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW (1999) Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 274:23463-7
6. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47:1953-9
7. Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC, Jr (2002) Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 80:667-77
8. Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, Matter K (1996) Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134:1031-49
9. Barber AJ, Antonetti DA (2003) Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Invest Ophthalmol Vis Sci 44:5410-6
10. Barber AJ, Antonetti DA, Gardner TW (2000) Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 41:3561-8
11. Bauer HC, Bauer H, Lametschwandtner A, Amberger A, Ruiz P, Steiner M (1993) Neovascularization and the appearance of morphological characteristics of the blood-brain barrier in the embryonic mouse central nervous system. Brain Res Dev Brain Res 75:269-78
12. Bazzoni G, Martinez-Estrada OM, Mueller F, Nelboeck P, Schmid G, Bartfai T, Dejana E, Brockhaus M (2000) Homo-philic interaction of junctional adhesion molecule. J Biol Chem 275:30970-6
13. Ben-Yosef T, Belyantseva IA, Saunders TL, Hughes ED, Kawamoto K, Van Itallie CM, Beyer LA, Halsey K, Gardner DJ, Wilcox ER, Rasmussen J, Anderson JM, Dolan DF, Forge A, Raphael Y, Camper SA, Friedman TB (2003) Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Hum Mol Genet 12:2049-61
14. Bendayan R, Lee G, Bendayan M (2002) Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc Res Tech 57:365-80
15. Bergersen L, Johannsson E, Veruki ML, Nagelhus EA, Halestrap A, Sejersted OM, Ottersen OP (1999) Cellular and subcellular expression of monocarboxylate transporters in the pigment epithelium and retina of the rat. Neuroscience 90:319-31
16. Bertossi M, Virgintino D, Maiorano E, Occhiogrosso M, Roncali L (1997) Ultrastructural and morphometric investigation of human brain capillaries in normal and peritu-moral tissues. Ultrastruct Pathol 21:41-9
17. Boivin D, Bilodeau D, Beliveau R (1996) Regulation of cyto-skeletal functions by Rho small GTP-binding proteins in normal and cancer cells. Can J Physiol Pharmacol 74:801-10
18. Botchkin LM, Matthews G (1993) Chloride current activated by swelling in retinal pigment epithelium cells. Am J Physiol 265:C1037-45
19. Brightman MW, Reese TS (1969) Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 40:648-77
20. Burdo JR, Antonetti DA, Wolpert EB, Connor JR (2003) Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system. Neuroscience 121:883-90
21. Burgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M, Schulzke JD (2002) Mechanisms of diarrhea in collagenous colitis. Gastroenterology 123:433-43
22. Cau J, Hall A (2005) Cdc42 controls the polarity of the actin and microtubule cytoskeletons through two distinct signal transduction pathways. J Cell Sci 118:2579-87
23. Chakravarthy U, Hayes RG, Stitt AW, Douglas A (1997) Endothelin expression in ocular tissues of diabetic and insulin-treated rats. Invest Ophthalmol Vis Sci 38:2144-51
24. Chen Y, Lu Q, Schneeberger EE, Goodenough DA (2000) Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 11:849-62
25. Clermont AC, Cahill M, Salti H, Rook SL, Rask-Madsen C, Goddard L, Wong JS, Bursell D, Bursell SE, Aiello LP (2006) Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics. Invest Ophthalmol Vis Sci 47:2701-8
26. Colegio OR, Van Itallie CM, McCrea HJ, Rahner C, Anderson JM (2002) Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Phy-siol Cell Physiol 283:C142-7
27. Coomber BL, Stewart PA (1986) Three-dimensional reconstruction of vesicles in endothelium of blood-brain barrier versus highly permeable microvessels. Anat Rec 215:256-61
28. Cordenonsi M, D'Atri F, Hammar E, Parry DA, Kendrick-Jones J, Shore D, Citi S (1999) Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin. J Cell Biol 147:1569-82
29. Crocker DJ, Murad TM, Geer JC (1970) Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol 13:51-65
30. Crook M (2004) Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabet Med 21:203-7
31. Cunha-Vaz J, Bernardes R (2005) Nonproliferative retinop-athy in diabetes type 2. Initial stages and characterization of phenotypes. Prog Retin Eye Res 24:355-77
32. Cunha-Vaz J, Lobo C, Sousa JC, Oliveiros B, Leite E, de Abreu JR (1998) Progression of retinopathy and alteration of the blood-retinal barrier in patients with type 2 diabetes: a 7-year prospective follow-up study. Graefes Arch Clin Exp Ophthalmol 236:264-8
33. Cunningham SA, Rodriguez JM, Arrate MP, Tran TM, Brock TA (2002) JAM2 interacts with alpha4beta1. Facilitation by JAM3. J Biol Chem 277:27589-92
34. D'Atri F, Citi S (2001) Cingulin interacts with F-actin in vitro. FEBS Lett 507:21-4
35. Damas J (1998) [Starling's law in 1998]. Rev Med Liege 53:425-30
36. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-9
37. Deen WM, Lazzara MJ, Myers BD (2001) Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 281:F579-96
38. DeMaio L, Antonetti DA, Scaduto RC, Jr, Gardner TW, Tar-bell JM (2004) VEGF increases paracellular transport without altering the solvent-drag reflection coefficient. Micro-vasc Res 68:295-302
39. DeMaio L, Chang YS, Gardner TW, Tarbell JM, Antonetti DA (2001) Shear stress regulates occludin content and phosphorylation. Am J Physiol Heart Circ Physiol 281: H105-13
40. Dermietzel R, Krause D (1991) Molecular anatomy of the blood-brain barrier as defined by immunocytochemistry. Int Rev Cytol 127:57-109
41. Duncan BB, Schmidt MI (2006) The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Diabetes Technol Ther 8:7-17
42. Ebnet K, Suzuki A, Ohno S, Vestweber D (2004) Junctional adhesion molecules (JAMs): more molecules with dual functions? J Cell Sci 117:19-29
43. Enea NA, Hollis TM, Kern JA, Gardner TW (1989) Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes. Arch Ophthalmol 107:270-4
44. Engler C, Krogsaa B, Lund-Andersen H (1991) Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study. Graefes Arch Clin Exp Ophthalmol 229:442-6
45. Etienne-Manneville S, Hall A (2003) Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421:753-6
46. Fanning AS, Anderson JM (1999) Protein modules as organizers of membrane structure. Curr Opin Cell Biol 11:432-9
47. Fanning AS, Ma TY, Anderson JM (2002) Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB J 16:1835-7
48. Farquhar MG, Palade GE (1963) Junctional complexes in various epithelia. J Cell Biol 17:375-412
49. Fenstermacher J, Gross P, Sposito N, Acuff V, Pettersen S, Gruber K (1988) Structural and functional variations in capillary systems within the brain. Ann N Y Acad Sci 529:21-30
50. Festa A, D'Agostino R, Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42-7
51. Frank RN (1991) On the pathogenesis of diabetic retinopa-thy. A 1990 update. Ophthalmology 98:586-93
52. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W (2000) Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23:1835-9
53. Fujimoto K (1995) Pericyte-endothelial gap junctions in developing rat cerebral capillaries: a fine structural study. Anat Rec 242:562-5
54. Fukuhara A, Irie K, Nakanishi H, Takekuni K, Kawakatsu T, Ikeda W, Yamada A, Katata T, Honda T, Sato T, Shimizu K, Ozaki H, Horiuchi H, Kita T, Takai Y (2002) Involvement of nectin in the localization of junctional adhesion molecule at tight junctions. Oncogene 21:7642-55
55. Fukuhara A, Irie K, Yamada A, Katata T, Honda T, Shimizu K, Nakanishi H, Takai Y (2002) Role of nectin in organization of tight junctions in epithelial cells. Genes Cells 7: 1059-72
56. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugita-ni Y, Noda T, Kubo A, Tsukita S (2002) Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156: 1099-111
57. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsu-kita S, Tsukita S (1993) Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123:1777-88
58. Garcia PJ, Spellman CW (2006) Should all diabetic patients receive statins? Curr Atheroscler Rep 8:13-8
59. Gardiner TA, Anderson HR, Stitt AW (2003) Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J Pathol 201:328-33
60. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Naka-mura M (2000) New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets. Diabetes Technol Ther 2:601-8
61. Goldstein B (2000) Embryonic polarity: a role for microtu-bules. Curr Biol 10:R820-2
62. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE (2003) Tight junction proteins. Prog Biophys Mol Biol 81:1-44
63. Guillemot L, Hammar E, Kaister C, Ritz J, Caille D, Jond L, Bauer C, Meda P, Citi S (2004) Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci 117:5245-56
64. Gumbiner B, Lowenkopf T, Apatira D (1991) Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1. Proc Natl Acad Sci U S A 88:3460-4
65. Guo P, Weinstein AM, Weinbaum S (2003) A dual-pathway ultrastructural model for the tight junction of rat proximal tubule epithelium. Am J Physiol Renal Physiol 285:F241-57
66. Guo S, Kemphues KJ (1996) Molecular genetics of asymmetric cleavage in the early Caenorhabditis elegans embryo. Curr Opin Genet Dev 6:408-15
67. Haffner SM (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97:3A-11A
68. Hammes HP (2005) Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 37 Suppl 1:39-43
69. Hammes HP, Lin J, Wagner P, Feng Y, Vom Hagen F, Krzizok T, Renner O, Breier G, Brownlee M, Deutsch U (2004) Angi-opoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 53:1104-10
70. Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA (2006) VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. IOVS (in press)
71. Haskins J, Gu L, Wittchen ES, Hibbard J, Stevenson BR (1998) ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occlu-din. J Cell Biol 141:199-208
72. Hirase T, Kawashima S, Wong EY, Ueyama T, Rikitake Y, Tsukita S, Yokoyama M, Staddon JM (2001) Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and-independent mechanisms. J Biol Chem 276:10423-31
73. Hirase T, Staddon JM, Saitou M, Ando-Akatsuka Y, Itoh M, Furuse M, Fujimoto K, Tsukita S, Rubin LL (1997) Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 110(14):1603-13
74. Hirschi KK, D'Amore PA (1997) Control of angiogenesis by the pericyte: molecular mechanisms and significance. EXS 79:419-28
75. Hofman P, van Blijswijk BC, Gaillard PJ, Vrensen GF, Schlingemann RO (2001) Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusi-on. Arch Ophthalmol 119:861-6
76. Hurd TW, Gao L, Roh MH, Macara IG, Margolis B (2003) Direct interaction of two polarity complexes implicated in epithelial tight junction assembly. Nat Cell Biol 5:137-42
77. Jiang WG, Martin TA, Matsumoto K, Nakamura T, Mansel RE (1999) Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J Cell Physiol 181: 319-29
78. Jin M, Barron E, He S, Ryan SJ, Hinton DR (2002) Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor. Invest Ophthalmol Vis Sci 43:2782-90
79. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158:147-52
80. Katsura Y, Okano T, Noritake M, Kosano H, Nishigori H, Kado S, Matsuoka T (1998) Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopa-thy and other retinal disorders. Diabetes Care 21: 1759-63
81. 2+ transport function of Claudin-16. J Clin Invest 116:878-91
82. Kinukawa Y, Shimura M, Tamai M (1999) Quantifying leukocyte dynamics and plugging in retinal microcirculation of streptozotosin-induced diabetic rats. Curr Eye Res 18:49-55
83. Kliche S, Waltenberger J (2001) VEGF receptor signaling and endothelial function. IUBMB Life 52:61-6
84. Knoblich JA (2001) Asymmetric cell division during animal development. Nat Rev Mol Cell Biol 2:11-20
85. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W (1998) Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 8:529-32
86. Korte GE, Burns MS, Bellhorn RW (1989) Epithelium-capillary interactions in the eye: the retinal pigment epithelium and the choriocapillaris. Int Rev Cytol 114:221-48
87. Kowluru RA (2005) Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal 7:1581-87
88. Kowluru RA (2005) Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions. Life Sci 76:1051-60
89. Kowluru RA, Atasi L, Ho YS (2006) Role of mitochondrial superoxide dismutase in the development of diabetic reti-nopathy. Invest Ophthalmol Vis Sci 47:1594-9
90. Kowluru RA, Kennedy A (2001) Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opin Inve-stig Drugs 10:1665-76
91. Kuriyama M, Harada N, Kuroda S, Yamamoto T, Nakafuku M, Iwamatsu A, Yamamoto D, Prasad R, Croce C, Canaani E, Kaibuchi K (1996) Identification of AF-6 and canoe as putative targets for Ras. J Biol Chem 271:607-10
92. Lacaz-Vieira F, Jaeger MM, Farshori P, Kachar B (1999) Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resea-ling. J Membr Biol 168:289-97
93. Lecaire T, Palta M, Zhang H, Allen C, Klein R, D'Alessio D (2006) Lower-than-expected prevalence and severity of ret-inopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: The Wisconsin Diabetes Registry Study. Am J Epidemiol 164:143-50
94. Lin J, Bierhaus A, Bugert P, Dietrich N, Feng Y, Vom Hagen F, Nawroth P, Brownlee M, Hammes HP (2006) Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia 49:1089-96
95. Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C (2003) Endothelial PDGF-B retention is required for proper investment of pericytes in the micro-vessel wall. Genes Dev 17:1835-40
96. Ling V (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40 Suppl:S3-8
97. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP (1998) Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101:1219-24
98. Lu M, Perez VL, Ma N, Miyamoto K, Peng HB, Liao JK, Ada-mis AP (1999) VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci 40:1808-12
99. Lutty GA, McLeod DS, Merges C, Diggs A, Plouet J (1996) Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 114:971-7
100. Maines LW, Antonetti DA, Wolpert EB, Smith CD (2005) Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells. Neuropharmacology 49: 610-7
101. Mandell KJ, Parkos CA (2005) The JAM family of proteins. Adv Drug Deliv Rev 57:857-67
102. Marmor MF, Wolfensberger TJ (1998) The retinal pigment epithelium: function and disease. Oxford University Press, New York
103. Masuzawa K, Goto K, Jesmin S, Maeda S, Miyauchi T, Kaji Y, Oshika T, Hori S (2006) An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Curr Eye Res 31:79-89
104. Mazzon E, Puzzolo D, Caputi AP, Cuzzocrea S (2002) Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Mol Med 8:353-66
105. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsuki-ta S, Rogers RA, Lynch RD, Schneeberger EE (1996) Occlu-din is a functional component of the tight junction. J Cell Sci 109(9):2287-98
106. McNeil E, Capaldo CT, Macara IG (2006) Zonula occlu-dens-1 function in the assembly of tight junctions in Madin-Darby canine kidney epithelial cells. Mol Biol Cell 17:1922-32
107. Miller SS, Edelman JL (1990) Active ion transport pathways in the bovine retinal pigment epithelium. J Physiol 424: 283-300
108. Miller SS, Hughes BA, Machen TE (1982) Fluid transport across retinal pigment epithelium is inhibited by cyclic AMP. Proc Natl Acad Sci U S A 79:2111-5
109. Miller SS, Steinberg RH (1977) Active transport of ions across frog retinal pigment epithelium. Exp Eye Res 25: 235-48
110. Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J (2000) Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Am J Ophthalmol 129:678-80
111. Mitic LL, Anderson JM (1998) Molecular architecture of tight junctions. Annu Rev Physiol 60:121-42
112. Miyamoto K, Hiroshiba N, Tsujikawa A, Ogura Y (1998) In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthal-mol Vis Sci 39:2190-4
113. Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, Adamis AP (2000) Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 156:1733-9
114. Miyoshi J, Takai Y (2005) Molecular perspective on tight-junction assembly and epithelial polarity. Adv Drug Deliv Rev 57:815-55
115. Moore TC, Moore JE, Kaji Y, Frizzell N, Usui T, Poulaki V, Campbell IL, Stitt AW, Gardiner TA, Archer DB, Adamis AP (2003) The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 44:4457-64
116. Morcos Y, Hosie MJ, Bauer HC, Chan-Ling T (2001) Immu-nolocalization of occludin and claudin-1 to tight junctions in intact CNS vessels of mammalian retina. J Neurocytol 30:107-23
117. Moss SE, Klein R, Klein BE (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105: 998-1003
118. Murata T, Ishibashi T, Inomata H (1993) Immunohisto-chemical detection of blood-retinal barrier breakdown in streptozotocin-diabetic rats. Graefes Arch Clin Exp Oph-thalmol 231:175-7
119. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K (1996) The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 74:819-25
120. Nagy Z, Peters H, Huttner I (1984) Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab Invest 50:313-22
121. Nehls V, Denzer K, Drenckhahn D (1992) Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270:469-74
122. Nelson WJ (2003) Adaptation of core mechanisms to generate cell polarity. Nature 422:766-74
123. Nielsen S, Smith BL, Christensen EI, Agre P (1993) Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia. Proc Natl Acad Sci U S A 90:7275-9
124. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653-60
125. Nusrat A, Brown GT, Tom J, Drake A, Bui TT, Quan C, Mrsny RJ (2005) Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin. Mol Biol Cell 16:1725-34
126. Oldendorf WH, Cornford ME, Brown WJ (1977) The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endotheli-al cells in brain and other tissues of the rat. Ann Neurol 1:409-17
127. Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C (2002) JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 3:151-8
128. Pardridge WM, Boado RJ, Farrell CR (1990) Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem 265:18035-40
129. Petronczki M, Knoblich JA (2001) DmPAR-6 directs epithelial polarity and asymmetric cell division of neurob-lasts in Drosophila. Nat Cell Biol 3:43-9
130. Philp NJ, Yoon H, Grollman EF (1998) Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. Am J Physiol 274:R1824-8
131. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-8
132. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42:2408-13
133. Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, Piwnica-Worms D (1999) Choroid plexus epithelial expression of MDR1 P glycoprotein and mul-tidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci U S A 96:3900-5
134. Rizzolo LJ (1997) Polarity and the development of the outer blood-retinal barrier. Histol Histopathol 12:1057-67
135. Roh MH, Fan S, Liu CJ, Margolis B (2003) The Crumbs3-Pals1 complex participates in the establishment of polarity in mammalian epithelial cells. J Cell Sci 116:2895-906
136. Roh MH, Liu CJ, Laurinec S, Margolis B (2002) The car-boxyl terminus of zona occludens-3 binds and recruits a mammalian homologue of discs lost to tight junctions. J Biol Chem 277:27501-9
137. Romero IA, Radewicz K, Jubin E, Michel CC, Greenwood J, Couraud PO, Adamson P (2003) Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci Lett 344:112-6
138. Rothenberg M, Ling V (1989) Multidrug resistance: molecular biology and clinical relevance. J Natl Cancer Inst 81:907-10
139. Rubin LL, Staddon JM (1999) The cell biology of the blood-brain barrier. Annu Rev Neurosci 22:11-28
140. 2+](in) and KCl-coupled fluid absorption in bovine RPE. Invest Ophthalmol Vis Sci 42: 1921-9
141. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S (2000) Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11:4131-42
142. Salathe EP, Venkataraman R (1982) Interaction of fluid movement and particle diffusion across capillary walls. J Biomech Eng 104:57-62
143. Sasaki H, Matsui C, Furuse K, Mimori-Kiyosue Y, Furuse M, Tsukita S (2003) Dynamic behavior of paired claudin strands within apposing plasma membranes. Proc Natl Acad Sci U S A 100:3971-6
144. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fuji-wara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-4
145. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Roba-nus-Maandag EC, te Riele HP, et al. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502
146. Schinkel AH, Wagenaar E, Mol CA, van Deemter L (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97:2517-24
147. Schlingemann RO, van Hinsbergh VW (1997) Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol 81:501-12
148. Schulzke JD, Gitter AH, Mankertz J, Spiegel S, Seidler U, Amasheh S, Saitou M, Tsukita S, Fromm M (2005) Epithelial transport and barrier function in occludin-deficient mice. Biochim Biophys Acta 1669:34-42
149. Sedlakova R, Shivers RR, Del Maestro RF (1999) Ultrastructure of the blood-brain barrier in the rabbit. J Sub-microsc Cytol Pathol 31:149-61
150. Senger DR, Perruzzi CA, Feder J, Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-32
151. Shin K, Straight S, Margolis B (2005) PATJ regulates tight junction formation and polarity in mammalian epithelial cells. J Cell Biol 168:705-11
152. Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Matsu-zaki T, Takayama M, Shinmura K, Yamada M (1999) Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol 83:834-7
153. Stamer WD, Bok D, Hu J, Jaffe GJ, McKay BS (2003) Aqua-porin-1 channels in human retinal pigment epithelium: role in transepithelial water movement. Invest Ophthal-mol Vis Sci 44:2803-8
154. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA (1986) Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 103:755-66
155. Stewart PA, Hayakawa K (1994) Early ultrastructural changes in blood-brain barrier vessels of the rat embryo. Brain Res Dev Brain Res 78:25-34
156. Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826-32
157. Stitt AW (2003) The role of advanced glycation in the path-ogenesis of diabetic retinopathy. Exp Mol Pathol 75: 95-108
158. Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85:845-81
159. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-80
160. Suzuki A, Ishiyama C, Hashiba K, Shimizu M, Ebnet K, Ohno S (2002) aPKC kinase activity is required for the asymmetric differentiation of the premature junctional complex during epithelial cell polarization. J Cell Sci 115:3565-73
161. Suzuki A, Yamanaka T, Hirose T, Manabe N, Mizuno K, Shimizu M, Akimoto K, Izumi Y, Ohnishi T, Ohno S (2001) Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J Cell Biol 152:1183-96
162. Szkudelski T (2001) The mechanism of alloxan and strep-tozotocin action in B cells of the rat pancreas. Physiol Res 50:537-46
163. Takagi C, Bursell SE, Lin YW, Takagi H, Duh E, Jiang Z, Cler-mont AC, King GL (1996) Regulation of retinal hemody-namics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci 37:2504-18
164. Tavelin S, Hashimoto K, Malkinson J, Lazorova L, Toth I, Artursson P (2003) A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol 64:1530-40
165. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-86
166. The Diabetes Control and Complications Trial Research Group (1998) Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Oph-thalmol 116:874-86.
167. Turksen K, Troy TC (2004) Barriers built on claudins. J Cell Sci 117:2435-47
168. Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H, Honda Y, Wiegand SJ, Yancopoulos GD, Nishika-wa S (2002) Recombinant angiopoietin-1 restores higherorder architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 110:1619-28
169. Umeda K, Matsui T, Nakayama M, Furuse K, Sasaki H, Furuse M, Tsukita S (2004) Establishment and characterization of cultured epithelial cells lacking expression of ZO-1. J Biol Chem 279:44785-94
170. Van Itallie CM, Anderson JM (1997) Occludin confers adhesiveness when expressed in fibroblasts. J Cell Sci 110(9):1113-21
171. Van Itallie CM, Fanning AS, Anderson JM (2003) Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol 285:F1078-84
172. Vialettes B, Silvestre-Aillaud P, Atlan-Gepner C (1994) [Outlook for the future in the treatment of diabetic reti-nopathy]. Diabetes Metab 20:229-34
173. Vietor I, Bader T, Paiha K, Huber LA (2001) Perturbation of the tight junction permeability barrier by occludin loop peptides activates beta-catenin/TCF/LEF-mediated transcription. EMBO Rep 2:306-12
174. Vincent AM, Brownlee M, Russell JW (2002) Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci 959:368-83
175. Vinores SA, McGehee R, Lee A, Gadegbeku C, Campochia-ro PA (1990) Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats. J Histochem Cytochem 38:1341-52
176. Vitale S, Maguire MG, Murphy RP, Hiner CJ, Rourke L, Sackett C, Patz A (1995) Clinically significant macular edema in type I diabetes. Incidence and risk factors. Ophthalmology 102:1170-6
177. Vorbrodt AW, Dobrogowska DH (2003) Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view. Brain Res Brain Res Rev 42:221-42
178. Walsh SV, Hopkins AM, Nusrat A (2000) Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev 41:303-13
179. Wang W, Dentler WL, Borchardt RT (2001) VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 280:H434-40
180. Wang Z, Mandell KJ, Parkos CA, Mrsny RJ, Nusrat A (2005) The second loop of occludin is required for suppression of Raf1-induced tumor growth. Oncogene 24: 4412-20
181. Wen H, Watry DD, Marcondes MC, Fox HS (2004) Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5. Mol Cell Biol 24:8408-17
182. Wilcox ER, Burton QL, Naz S, Riazuddin S, Smith TN, Ploplis B, Belyantseva I, Ben-Yosef T, Liburd NA, Morell RJ, Kachar B, Wu DK, Griffith AJ, Riazuddin S, Friedman TB (2001) Mutations in the gene encoding tight junction clau-din-14 cause autosomal recessive deafness DFNB29. Cell 104:165-72
183. Williams CD, Rizzolo LJ (1997) Remodeling of junctional complexes during the development of the outer blood-retinal barrier. Anat Rec 249:380-8
184. Wittchen ES, Haskins J, Stevenson BR (1999) Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 274:35179-85
185. Wolburg H, Lippoldt A (2002) Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 38:323-37
186. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Egg-stein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B (2003) Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol (Berl) 105:586-92
187. Wolburg H, Wolburg-Buchholz K, Liebner S, Engelhardt B (2001) Claudin-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse. Neurosci Lett 307:77-80
188. Wong V, Gumbiner BM (1997) A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136: 399-409
189. Wu X, Zhao X, Baylor L, Kaushal S, Eisenberg E, Greene LE (2001) Clathrin exchange during clathrin-mediated endo-cytosis. J Cell Biol 155:291-300
190. Xu Q, Qaum T, Adamis AP (2001) Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 42:789-94
191. Yamamoto T, Harada N, Kano K, Taya S, Canaani E, Mat-suura Y, Mizoguchi A, Ide C, Kaibuchi K (1997) The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol 139:785-95
192. Yamanaka T, Horikoshi Y, Suzuki A, Sugiyama Y, Kitamu-ra K, Maniwa R, Nagai Y, Yamashita A, Hirose T, Ishikawa H, Ohno S (2001) PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex. Genes Cells 6: 721-31
193. Yokota T, Ma RC, Park JY, Isshiki K, Sotiropoulos KB, Rau-niyar RK, Bornfeldt KE, King GL (2003) Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes 52:838-45
194. Yoon H, Fanelli A, Grollman EF, Philp NJ (1997) Identification of a unique monocarboxylate transporter (MCT3) in retinal pigment epithelium. Biochem Biophys Res Commun 234:90-4
195. Yu AS, McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, Lynch RD, Schneeberger EE (2005) Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol 288:C1231-41
196. Zettl KS, Sjaastad MD, Riskin PM, Parry G, Machen TE, Firestone GL (1992) Glucocorticoid-induced formation of tight junctions in mouse mammary epithelial cells in vitro. Proc Natl Acad Sci U S A 89:9069-73
197. Aiello LP (2002) The potential role of PKC beta in diabetic retinopathy and macular edema. Surv Ophthalmol 47 Suppl 2:S263-S269
198. Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, et al. (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selec-tive inhibitor. Diabetes 46(9):1473-1480
199. Alikacem N, Yoshizawa T, Nelson KD, Wilson CA (2000) Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits. Invest Ophthalmol Vis Sci 41(6):1561-1569
200. Ando N, Sen HA, Berkowitz BA, Wilson CA, de Juan E, Jr (1994) Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretino-pathy. Arch Ophthalmol 112(1):117-122
201. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47(12):1953-1959
202. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102(4):783-791
203. Berkowitz BA, Roberts R, Luan H, Peysakhov J, Mao X, Thomas KA (2004) Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats. Invest Ophthalmol Vis Sci 45(7): 2391-2398
204. Berkowitz BA, Sato Y, Wilson CA, de Juan E (1991) Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetria-minepentaacetic acid injection. Invest Ophthalmol Vis Sci 32(11):2854-2860
205. Berkowitz BA, Tofts PS, Sen HA, Ando N, de Juan E, Jr (1992) Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI. Invest Ophthalmol Vis Sci 33(13):3500-3506
206. Berkowitz BA, Wilson CA, Tofts PS, Peshock RM (1994) Effect of vitreous fluidity on the measurement of blood-retinal barrier permeability using contrast-enhanced MRI. Magn Reson Med 31(1):61-66
207. Caspers-Velu LE, Wadhwani KC, Rapoport SI, Kador PF (1995) Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats. J Ocul Pharmacol Ther 11(3):469-487
208. Cunha-Vaz JG (2004) The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res 78(3): 715-721
209. Cunningham SA, Stephan CC, Arrate MP, Ayer KG, Brock TA (1997) Identification of the extracellular domains of Flt-1 that mediate ligand interactions. Biochem Biophys Res Commun 231(3):596-599
210. Cunningham SA, Tran TM, Arrate MP, Brock TA (1999) Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase. A real time kinetic study. J Biol Chem 274(26):18421-18427
211. Dallal MM, Chang SW (1994) Evans blue dye in the assessment of permeability-surface area product in perfused rat lungs. J Appl Physiol 77(2):1030-1035
212. Derevjanik NL, Vinores SA, Xiao WH, Mori K, Turon T, Hudish T, et al. (2002) Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest Ophthalmol Vis Sci 43(7):2462-2467
213. DiMattio J (1991) In vivo use of neutral radiolabelled molecular probes to evaluate blood-ocular barrier integrity in normal and streptozotocin-diabetic rats. Diabetologia 34(12):862-867
214. Enea NA, Hollis TM, Kern JA, Gardner TW (1989) Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes. Arch Ophthalmol 107(2):270-274
215. Ennis SR (1990) Permeability of the blood-ocular barrier to mannitol and PAH during experimental diabetes. Curr Eye Res 9(9):827-838
216. Ennis SR, Betz AL (1986) Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate. Invest Ophthalmol Vis Sci 27(7): 1095-1102
217. Ferris FL, III, Patz A (1984) Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol 28 Suppl: 452-461
218. Frank JA, Dwyer AJ, Girton M, Knop RH, Sank VJ, Gansow OA, et al. (1986) Opening of blood-ocular barrier demonstrated by contrast-enhanced MR imaging. J Comput Assist Tomogr 10(6):912-916
219. Funatsu H, Wilson CA, Berkowitz BA, Sonkin PL (1997) A comparative study of the effects of argon and diode laser photocoagulation on retinal oxygenation. Graefes Arch Clin Exp Ophthalmol 235(3):168-175
220. Garner WH, Scheib S, Berkowitz BA, Suzuki M, Wilson CA, Graff G (2001) The effect of partial vitrectomy on blood-ocular barrier function in the rabbit. Curr Eye Res 23(5):372-381
221. Grimes PA (1985) Fluorescein distribution in retinas of normal and diabetic rats. Exp Eye Res 41(2):227-238
222. Grimes PA (1988) Carboxyfluorescein distribution in ocular tissues of normal and diabetic rats. Curr Eye Res 7(10):981-988
223. Jones CW, Cunha-Vaz JG, Rusin MM (1982) Vitreous fluo-rophotometry in the alloxan-and streptozocin-treated rat. Arch Ophthalmol 100(7):1141-1145
224. Kent D, Vinores SA, Campochiaro PA (2000) Macular oedema: the role of soluble mediators. Br J Ophthalmol 84(5): 542-545
225. Kirber WM, Nichols CW, Grimes PA, Winegrad AI, Laties AM (1980) A permeability defect of the retinal pigment epi-thelium. Occurrence in early streptozocin diabetes. Arch Ophthalmol 98(4):725-728
226. Lightman S, Pinter G, Yuen L, Bradbury M (1990) Permeability changes at blood-retinal barrier in diabetes and effect of aldose reductase inhibition. Am J Physiol 259: R601-R605
227. Lightman S, Rechthand E, Terubayashi H, Palestine A, Rap-aport S, Kador P (1987) Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors. Diabetes 36:1271-1275
228. Lobo C, Bernardes R, Faria d A, Jr, Cunha-Vaz JG (1999) Novel imaging techniques for diabetic macular edema. Doc Ophthalmol 97(3-4):341-347
229. Luan H, Roberts R, Sniegowski M, Goebel DJ, Berkowitz BA (2006) Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 47(1):320-8
230. Lukaszew RA, Mullins CM, Penn JS, Berkowitz BA (1997) Noninvasive and quantitative staging of hyaloidopathy in experimental retinopathy of prematurity. Invest Ophthal-mol Vis Sci 38(4):S747
231. Lund-Andersen H (2002) Mechanisms for monitoring changes in retinal status following therapeutic intervention in diabetic retinopathy. Surv Ophthalmol 47 Suppl 2:S270-S277
232. Maepea O, Karlsson C, Alm A (1984) Blood-ocular and blood-brain barrier function in streptozocin-induced diabetes in rats. Arch Ophthalmol 102(9):1366-1369
233. Marmor MF (1999) Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol 97(3-4):239-249
234. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45(9):3330-3336
235. Mathews MK, Merges C, McLeod DS, Lutty GA (1997) Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci 38(13):2729-2741
236. Mayhan WG (2001) Regulation of blood-brain barrier permeability. Microcirculation 8(2):89-104
237. Menzies SA, Hoff JT, Betz AL (1990) Extravasation of albumin in ischaemic brain oedema. Acta Neurochir Suppl (Wien) 51:220-222
238. Metrikin DC, Wilson CA, Berkowitz BA, Lam MK, Wood GK, Peshock RM (1995) Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis. Invest Ophthalmol Vis Sci 36(7):1361-1370
239. Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Ino-mata H (1995) Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 27(1):48-52
240. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K (1996) The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 74(4):819-825
241. Nagy Z, Szabo M, Huttner I (1985) Blood-brain barrier impairment by low pH buffer perfusion via the internal carotid artery in rat. Acta Neuropathol (Berl) 68(2): 160-163
242. Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH, et al. (2003) Apoptotic death of photoreceptors in the strepto-zotocin-induced diabetic rat retina. Diabetologia 46(9): 1260-1268
243. Pelc NJ (1993) Optimization of flip angle for T1 dependent contrast in MRI. Magn Reson Med 29(5):695-699
244. Plehwe WE, McRobbie DW, Lerski RA, Kohner EM (1988) Quantitative magnetic resonance imaging in assessment of the blood-retinal barrier. Invest Ophthalmol Vis Sci 29(5): 663-670
245. Prager TC, Chu HH, Garcia CA, Anderson RE (1982) The influence of vitreous change on vitreous fluorophotometry. Arch Ophthalmol 100(4):594-596
246. Prager TC, Chu HH, Garcia CA, Anderson RE, Field JB, Orzeck EA, et al. (1983) The use of vitreous fluorophotome-try to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement. Invest Ophthalmol Vis Sci 24(1):57-65
247. Prager TC, Wilson DJ, Avery GD, Merritt JH, Garcia CA, Hopen G, et al. (1981) Vitreous fluorophotometry: identification of sources of variability. Invest Ophthalmol Vis Sci 21(6):854-864
248. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, et al. (2001) VEGF-initiated blood retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42(10):2408-2413
249. Runge VM, Clanton JA, Lukehart CM, Partain CL, James AE, Jr (1983) Paramagnetic agents for contrast-enhanced NMR imaging: a review. AJR Am J Roentgenol 141(6): 1209-1215
250. Runge VM, Clanton JA, Price AC, Wehr CJ, Herzer WA, Par-tain CL, et al. (1985) The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption. Magn Reson Imaging 3(1):43-55
251. Sander B, Larsen M, Engler C, Moldow B, Lund-Andersen H (2002) Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier. Br J Ophthalmol 86(10):1139-1142
252. Sander B, Larsen M, Engler C, Strom C, Moldow B, Larsen N, et al. (2002) Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy. Br J Ophthalmol 86(3):316-320
253. Sander B, Larsen M, Moldow B, Lund-Andersen H (2001) Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Invest Oph-thalmol Vis Sci 42(2):433-438
254. Sato Y, Berkowitz BA, Wilson CA, de Juan E, Jr (1992) Blood-retinal barrier breakdown caused by diode vs argon laser endophotocoagulation. Arch Ophthalmol 110(2):277-281
255. Schmiedl U, Ogan MD, Moseley ME, Brasch RC (1986) Comparison of the contrast-enhancing properties of albu-min-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats. AJR Am J Roentgenol 147(6):1263-1270
256. Sen HA, Berkowitz BA, Ando N, de Juan E, Jr (1992) In vivo imaging of breakdown of the inner and outer blood-retinal barriers. Invest Ophthalmol Vis Sci 33(13):3507-3512
257. Tofts PS, Berkowitz BA (1993) Rapid measurement of capillary permeability using the early part of the dynamic Gd-DTPA MRI enhancement curve. J Magn Reson Series B 102:129-136
258. Tofts PS, Berkowitz BA (1994) Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. Magn Reson Imaging 12(1):81-91
259. Tornquist P, Alm A, Bill A (1990) Permeability of ocular vessels and transport across the blood-retinal-barrier. Eye 4(2):303-309
260. Trick GL, Liggett J, Levy J, Adamsons I, Edwards P, Desai U, et al. (2005) Dynamic contrast enhanced MRI in patients with diabetic macular edema: initial results. Exp Eye Res 81(1):97-102
261. Vinores SA, Derevjanik NL, Mahlow J, Berkowitz BA, Wilson CA (1998) Electron microscopic evidence for the mechanism of blood-retinal barrier breakdown in diabetic rabbits: comparison with magnetic resonance imaging. Pathol Res Pract 194(7):497-505
262. Vinores SA, McGehee R, Lee A, Gadegbeku C, Campochia-ro PA (1990) Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats. J Histochem Cytochem 38(9):1341-1352
263. Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA (1993) Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition. Exp Eye Res 57(6): 723-735
264. Wallow IH (1983) Posterior and anterior permeability defects? Morphologic observations on streptozotocin-treated rats. Invest Ophthalmol Vis Sci 24(9):1259-1268
265. Wilson CA, Berkowitz BA, Funatsu H, Metrikin DC, Harrison DW, Lam MK, et al. (1995) Blood-retinal barrier breakdown following experimental retinal ischemia and reperfusion. Exp Eye Res 61(5):547-557
266. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E, Jr (1992) Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 110(8):1155-1159
267. Wilson CA, Fleckenstein JL, Berkowitz BA, Green ME (1992) Preretinal neovascularization in diabetic retinopa-thy: a preliminary investigation using contrast-enhanced magnetic resonance imaging. J Diabetes Complications 6(4):223-229
268. Xu Q, Qaum T, Adamis AP (2001) Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 42(3):789-794
269. Yi-Ming W, Shu H, Miao CY, Shen FM, Jiang YY, Su DF (2004) Asynchronism of the recovery of baroreflex sensitivity, blood pressure, and consciousness from anesthesia in rats. J Cardiovasc Pharmacol 43(1):1-7